Novartis Gene Therapies, Inc.
FDA-inspected organization
Novartis Gene Therapies, Inc. has been audited by the FDA 3 times between 2021 and 2024 across all 2 sites.
Documents
FDA 483 Novartis Gene Therapies, Inc., Durham | 2024
Out of stock
FDA Investigators (12)
- Thai D. Truong, FDA Investigator
- Unnee Ranjan, FDA Investigator
- Burnell M. Henry, FDA Investigator
- Christine Harman, FDA Investigator
- Derya C. Coursey, FDA Investigator
- Andrew W. Harmon, FDA Investigator
- Lewis K. Antwi, FDA Investigator
- Steven E. Bowen, FDA Investigator
- Jacqueline M. Diaz Albert, FDA Investigator
- Jacqueline M. Diaz Albertini, FDA Investigator
- Diaz Albert, Jacqueline M, FDA Investigator
- Diaz Albertini, Jacqueline M, FDA Investigator